Adaptimmune Therapeutics Ownership | Who Owns Adaptimmune Therapeutics?
Adaptimmune Therapeutics Ownership Summary
Adaptimmune Therapeutics is owned by 59.29% institutional investors, 0.38% insiders, and 40.33% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 16.11% of ADAP shares. Edinburgh Worldwide Ord is the top mutual fund, with 2.91% of its assets in Adaptimmune Therapeutics shares.
ADAP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Adaptimmune Therapeutics | 59.29% | 0.38% | 40.33% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Matrix capital management company, lp | 38.97M | 16.11% | $38.00M |
| Ecor1 capital | 27.40M | 11.33% | $26.72M |
| Nea management company | 17.08M | 7.06% | $16.65M |
| Long focus capital management | 12.35M | 5.10% | $12.04M |
| Pfm health sciences, lp | 10.52M | 4.35% | $10.26M |
| Mpm asset management | 5.56M | 2.30% | $5.42M |
| Bioimpact capital | 5.10M | 2.11% | $4.97M |
| Bank of america corp /de/ | 4.65M | 1.92% | $4.53M |
| Rock springs capital management lp | 2.43M | 1.00% | $2.36M |
| Baillie gifford | 11.82M | 0.77% | $6.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 5.56M | 2.97% | $5.42M |
| Nea management company | 17.08M | 1.25% | $16.65M |
| Ecor1 capital | 27.40M | 0.82% | $26.72M |
| Bioimpact capital | 5.10M | 0.77% | $4.97M |
| Pfm health sciences, lp | 10.52M | 0.51% | $10.26M |
| Long focus capital management | 12.35M | 0.46% | $12.04M |
| Matrix capital management company, lp | 38.97M | 0.29% | $38.00M |
| Dafna capital management | 341.06K | 0.08% | $332.50K |
| Rock springs capital management lp | 2.43M | 0.07% | $2.36M |
| Key client fiduciary advisors | 255.36K | 0.06% | $137.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Long focus capital management | 12.35M | 0.46% | 1.66M |
| Renaissance | 1.79M | 0.00% | 394.57K |
| Jpmorgan chase | 1.04M | 0.00% | 122.21K |
| Pfm health sciences, lp | 10.52M | 0.51% | 97.10K |
| Lpl financial | 198.86K | 0.00% | 90.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | 11.82M | 0.00% | -4.96M |
| Baker bros. advisors lp | - | - | -2.34M |
| Tang capital management | - | - | -1.74M |
| Cubist systematic strategies | - | - | -675.88K |
| Acuitas investments | - | - | -541.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Invesco | 34.74K | - | 34.74K | $33.87K |
| Kingswood wealth advisors | 18.69K | 0.00% | 18.69K | $10.07K |
| Clear harbor asset management | 18.52K | 0.00% | 18.52K | $9.98K |
| Susquehanna group, llp | 11.70K | - | 11.70K | $11.35K |
| Ifp advisors | 3.02K | 0.00% | 3.02K | $2.95K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -10.00 |
| Royal bank of canada | -700.00 |
| Signaturefd | -2.04K |
| Wetzel investment advisors | -6.00K |
| Raymond james & associates | -10.22K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 79 | -1.25% | 151,643,820 | -1.46% | 59 | 1.46% | 36 | 56.52% | 15 | -31.82% |
| Jun 30, 2024 | 80 | -3.61% | 153,896,694 | -5.05% | 63 | 1.25% | 23 | -32.35% | 22 | - |
| Mar 31, 2024 | 83 | 9.21% | 162,089,971 | 12.87% | 71 | 0.64% | 34 | 21.43% | 22 | -12.00% |
| Dec 31, 2023 | 76 | -1.30% | 143,609,879 | -3.14% | 105 | 1.64% | 28 | 21.74% | 25 | 4.17% |
| Sep 30, 2023 | 77 | -11.49% | 148,269,557 | 2.49% | 80 | 1.05% | 23 | -59.65% | 24 | 118.18% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Edinburgh Worldwide Ord | 7.46M | 2.91% | - |
| Baillie Gifford Global Discovery A Acc | 3.29M | 1.29% | 16.81K |
| Baillie Gifford WW Discovery B USD Acc | 1.59M | 0.62% | 18.59K |
| JPM Thematics Genetic Thrps C2 dist USD | 916.30K | 0.36% | 3.13K |
| JPM Thematics Genetic Thrps C2 Acc USD | 913.17K | 0.36% | -26.08K |
| Galileo - Biotech Innovation Fund S USD | 752.46K | 0.29% | - |
| Mercer Global Small Cap Equity M-5£ | 538.31K | 0.21% | - |
| Mercer Global Small Cap Equity M-3£ | 484.78K | 0.19% | 84.40K |
| SPDR® Portfolio Developed Wld ex-US ETF | 266.09K | 0.10% | - |
| SEI International Equity F (SIT) | 246.74K | 0.10% | 71.50K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 17, 2025 | Norry Elliot | Chief Medical Officer | Sell | $3.24K |
| Jan 17, 2025 | Lunger John | Chief Patient Supply Officer | Sell | $3.24K |
| Jan 17, 2025 | Bertrand William C JR | Chief Operating Officer | Sell | $3.24K |
| Jan 17, 2025 | Rawcliffe Adrian | Chief Executive Officer | Sell | $17.77K |
| Jan 13, 2025 | Rawcliffe Adrian | Chief Executive Officer | Sell | $7.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 17 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 19 |
| 2023 Q4 | - | - |
ADAP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools